SARS-CoV-2 recombinant RBD vaccine

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

AAV5-BASED VACCINE AGAINST SARS-COV-2
EP 4185323 A4Applicant: BIOCAD JOINT STOCK COPriority: 2020
CN
EP
US
WO
4 publications
INFLUENZA VIRUS ENCODING A TRUNCATED NS1 PROTEIN AND A SARS-COV RECEPTOR BINDING DOMAIN
EP 4247420 A1Applicant: VIVALDI BIOSCIENCES INCPriority: 2020
EP
US
WO
4 publications
Vaccine composition for preventing human infection of SARS coronavirus and alleviating infection symptoms
US 11179459 B1Applicant: LIBENTECH CO LTDPriority: 2021
US
WO
2 publications
Three recombinant adenoviruses, RBD of SARS-CoV-2 Spike protein and application of three recombinant adenoviruses and RBD of SARS-CoV-2 Spike protein
CN 113583978 AApplicant: UNIV TSINGHUAPriority: 2020
CN
Corona Virus Disease 2019 (COVID-19) DNA vaccine and preparation method and application thereof
CN 111569057 AApplicant: JILIN ZHONGKE BIO ENG CO LTDPriority: 2020
CN
Neutralizing epitope peptide in RBD region of SARS-CoV-2 S protein and application of neutralizing epitope peptide
CN 114163504 AApplicant: MEISWEI SHANGHAI BIOTECHNOLOGY CO LTDPriority: 2020
CN
New coronavirus pneumonia vaccine and vaccine kit
CN 112626035 AApplicant: INST MICROBIOLOGY CASPriority: 2020
CN
AAV5-BASED VACCINE FOR INDUCTION OF SPECIFIC IMMUNITY AND/OR PREVENTION OF SARS-COV-2-RELATED INFECTION
WO 2022139631 A1Applicant: BIOCAD JOINT STOCK COPriority: 2020
WO
Recombinant ferritin nano-particles for expressing novel coronavirus RBD and construction method of recombinant ferritin nano-particles
CN 112851825 AApplicant: INST OF MILITARY VETERINARY MEDICINE ACADEMY OF MILITARY SCIENCESPriority: 2021
CN
RECOMBINANT SARS-CoV-2 IMMUNOGENIC PROTEIN PRODUCED IN PLANTS AND THE USE THEREOF
US 20250011371 A1Applicant: BAIYA PHYTOPHARM CO LTDPriority: 2021
US